Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

This study has been completed.

Study NCT00542971 Information provided by M.D. Anderson Cancer Center

First Received: October 10, 2007 Last Updated: July 26, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)